# Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx

> **NCT00002454** · PHASE2 · UNKNOWN · sponsor: **University of Medicine and Dentistry of New Jersey**

## Conditions studied

- Precancerous Condition

## Interventions

- **BIOLOGICAL:** autologous tumor cell vaccine

## Key facts

- **NCT ID:** NCT00002454
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1971-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002454, "Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00002454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*